Business: Borrowing Falls £20bn as Iran Hits UK Pharmacies
UK borrowing undershoots forecasts by £700m but Iran war lifts oil past $100 and paracetamol prices 30%, leaving Reeves's fiscal headroom exposed.
Editorial digest April 23, 2026
Last updated : 08:17
Two sets of numbers reached the Treasury before breakfast. The first brought relief: UK borrowing undershot the OBR's forecast by £700m for the year ending in March, with the deficit landing at £132bn, according to the Office for National Statistics. The second brought a warning: paracetamol is now 30% more expensive at the counter than in February, the National Pharmacy Association told The Guardian. Rachel Reeves got lucky on the books. She is about to lose that luck at the pharmacy counter.
Does the fiscal headroom survive the Iran war?
For a Chancellor pilloried over every revised growth figure, the March data is a small political gift. BBC News reports borrowing fell by £20bn across the year, as tax receipts more than absorbed higher spending. The OBR had penciled in a £132.7bn deficit; the actual figure came in £700m below.
What comes next is the problem. Brent crude crossed $100 again on Thursday as the Strait of Hormuz deadlock dragged on, The Guardian's business live reported. Sainsbury's warned the City it was "very unclear" how the Middle East war would hit profits, and held full-year operating profit guidance at £975m–£1,075m with unusual caveats about "buyer sentiment" and mortgage rates. When a supermarket starts hedging its outlook on a foreign conflict, the fiscal headroom the Treasury celebrated this morning is already thinner than it looks.
Why are paracetamol prices jumping 30%?
The war's most visible British price tag is not at the petrol pump. It is at the chemist's counter. The NPA told The Guardian that community pharmacies in England are charging 20–30% more for paracetamol than in February, and that some have run out of specific strengths of aspirin and co-codamol. Hay fever treatments are up by similar margins — timing that will bite just as pollen season peaks.
The mechanism is prosaic. Active pharmaceutical ingredients and packaging rely on global shipping routes and energy-hungry chemical plants. Layer oil at $100 and disrupted Gulf supply chains on top, and a 50p box of paracetamol becomes a political barometer. It also presses on an NHS open wound — a health service whose prescription drug budgets were squeezed long before any missiles flew.
Can the Tube keep running through RMT's four-day fight?
Back in London, a second 24-hour tube strike began at midday on Thursday with no fresh talks between RMT drivers and London Underground, The Guardian reported. The dispute is not about pay. That is the telling part. It is about London Underground's plan to let drivers opt into a voluntary four-day week — which the union argues would erode rostering protections for those who do not opt in.
This is a labour story with a larger subtext. "Voluntary" flexibility rarely stays voluntary once it is written into operational rosters, and the RMT knows it. For commuters, the practical outcome is two lost days this week. For City Hall, it is a preview of how post-pandemic work patterns — compressed hours, hybrid rostering, four-day weeks — now land on picket lines rather than HR slides.
What does Tesla's $25bn bet mean for UK investors?
Across the Atlantic, Tesla told investors it will spend more than $25bn this year on AI, robotics and chips, Reuters reports, with Elon Musk calling the outlay "well justified" against future revenue streams. Car sales are beside the point. The company is buying its way into an industrial AI bet whose payoff is measured in decades, not quarters.
UK pension funds and retail investors with Tesla exposure should read the statement plainly: this is a capex story now, not a delivery numbers story. The stock will trade on AI narrative, not on vehicle margins. Anyone still valuing Tesla as an automaker is mispricing the risk — in both directions.
What to take away
Reeves starts the day with a £700m forecast beat and ends it with pharmacists rationing co-codamol. The UK fiscal story in April 2026 is no longer about austerity versus stimulus. It is about whether a Chancellor can hold her numbers together while an external war eats the margin. On current oil prices, probably not.
